跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
Poractant alfa and beractant treatment of very premature infants with respiratory distress syndrome
A. M. Fujii, S. M. Patel, R. Allen, G. Doros,
C. Y. Guo
, S. Testa
公共衛生研究所
研究成果
:
Article
›
同行評審
42
引文 斯高帕斯(Scopus)
總覽
指紋
指紋
深入研究「Poractant alfa and beractant treatment of very premature infants with respiratory distress syndrome」主題。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Nursing and Health Professions
Prematurity
100%
Beractant
100%
Poractant Alfa
100%
Hyaline Membrane Disease
100%
Birth Weight
25%
Mean Airway Pressure
25%
Assisted Ventilation
25%
Surfactant
25%
Prevalence
12%
Neonatal Intensive Care Unit
12%
Combination Therapy
12%
Short Course Therapy
12%
Lung Dysplasia
12%
Pharmacology, Toxicology and Pharmaceutical Science
Prematurity
100%
Beractant
100%
Poractant Alfa
100%
Hyaline Membrane Disease
100%
Surfactant
25%
Prevalence
12%
Combination Therapy
12%
Randomized Controlled Trial
12%
Lung Dysplasia
12%
Keyphrases
Respiratory Distress Syndrome
100%
Surfactant
25%
Birth Weight
25%
Prematurity
25%
Respiratory Support
25%
Mean Airway Pressure
25%
United States
12%
Randomized Controlled Trial
12%
Treatment Efficacy
12%
Air Leak
12%
Hospitalization
12%
Premature Infant
12%
Preterm Infants
12%
Neonatal Intensive Care Unit
12%
Extubated
12%
Respiratory Index
12%
Short-term Treatment
12%
Short-term Benefits
12%
Animal-derived
12%
Mechanically Ventilated
12%
FiO2
12%
Initial Dose
12%
Bronchopulmonary Dysplasia
12%
Ventilated Infants
12%
Agricultural and Biological Sciences
Birth Weight
66%
Surfactant
66%